Biologic DMARD Tapering in RA

Belgian researchers sought to determine which patients are appropriate candidates for tapering biologics. In this article, we summarize their findings.

References:

1. Dierckx S, Lauwerys BR, Sokolova T, et al. Tapering of biological antirheumatic drugs in rheumatoid arthritis patients is achievable and cost effective in daily clinical practice: DATA from the Brussels UCL RA Cohort [abstract]. Arthritis Rheumatol. 2018;70(suppl 10).